… antiphospholipid syndrome was first recognized in patients with lupus, the stand alone
presentation of antiphospholipid syndrome … Studies of antiphospholipid syndrome pathogenesis …

… antiphospholipid syndrome (… antiphospholipid antibodies such as lupus anticoagulant,
anti-β-2-glycoprotein 1, and/or anticardiolipin antibodies. In the obstetrical APS, antiphospholipid …

… also key drivers of APS pathophysiology. Thrombotic events in … This review will highlight
known pathogenic factors in APS … a barrier that selectively permits molecular and cellular transit …

… injury by two pathogenic mechanisms: (i) complexes of TF with FVIIa and/or FVIIa-FXa
induce the production of TNF-α, interleukins and adhesion molecules by cleaving protease-…

… [20,21] As the pathogenesis of APS has been reviewed in … that may advance our understanding
of APS pathogenesis. … inflammatory molecules (intercellular cell adhesion molecule […

Antiphospholipid syndrome is an autoimmune systemic disorder characterized by arterial,
venous, or small vessel thrombosis and/or recurrent early pregnancy loss, fetal loss, or …

… antiphospholipid syndrome (APS) is still controversial and a matter of active debate. The
relevance of the IgA aB2GP1 isotype in the pathophysiology … , we summarize the molecular and …

… Antiphospholipid syndrome (APS) is a rare and complex autoimmune disorder … thrombosis
and pregnancy complications in the presence of antiphospholipid antibodies (aPL), including …

Antiphospholipid syndrome (APS), is an acquired autoimmune disorder characterised by
thrombosis, pregnancy morbidity, and the presence of antiphospholipid antibodies (aPL). …

… This review aims to summarize the present knowledge on the history, pathogenesis, clinical
… GPI molecule, that is the nonphospholipid binding tail of the molecule, are more pathogenic …